Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Fact or Myth? Aspirin for Primary Prevention

This program aims to help pharmacists maintain and enhance professional competencies to fulfill the following goals: 
- Ensure correct decision making in those patient populations in which aspirin for primary prevention is not recommended
- Satisfy education requirements for pharmacist re-licensure



CE Hours


CE Units


Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists


Accreditation Council for Pharmacy Education
Shenandoah University Bernard J. Dunn School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

To receive credit the following items must be completed

1. Register for the event through
2. Attend the entire activity
3. Complete all relevant learning assessments
4. Complete an activity evaluation through 


No external funding has been obtained for this activity. The speakers have no conflicts of interest to disclose and state that the decisions made for program development were free of the control of a commercial interest.





  • Understand the mechanism of action of aspirin in primary prevention
  • Understand the mechanism of bleeding risk associated with aspirin
  • Discuss the ASCEND, ARRIVE, and ASPREE trials and their findings
  • Recognize the patient populations in which aspirin for primary prevention is not recommended


Kelly Gray, PharmD
PGY-1 Resident, Valley Health

Activity Number


Release Date: May 20, 2020
Credit Expiration Date: May 20, 2023

CE Hours



Valley Health